Brokerages expect Jazz Pharmaceuticals plc – (NASDAQ:JAZZ) to post $432.77 million in sales for the current fiscal quarter, according to Zacks Investment Research. Nine analysts have made estimates for Jazz Pharmaceuticals’ earnings. The highest sales estimate is $448.38 million and the lowest is $419.09 million. Jazz Pharmaceuticals reported sales of $376.05 million during the same […]
